Reddit Posts
Mentions
I’ve been reading your posts carefully and have found them very helpful. Thank you for sharing your insights. At the moment, my portfolio mainly consists of ONDS, IMRX, and AMPX. During the current market pullback, if I were to add to my positions, which stock would you suggest focusing on? I’d really appreciate your thoughts
Intrested to know more about IMRX and your family that work there if you dont mind ?
I feel the best way to make money and not lose money in stocks is not to look for instant gratification. I only tried day trading once and lost like 140$ and took that as a lesson not to try this again and never tried it again. The way I think about risks with IMRX is that they have quite a long cash runway and if there is a "bump in the road" for them with trials, they've got time to figure things out.
I agree. I keep adding when I have extra cash. IMRX is one of my highest conviction trades of 2026. It might not be instant gratification, but I’m very confident in it. Unless there’s unforeseen problems with their med right off the bat in phase 3, I think it will be a 2x by later in the summer .
been that way for some time, if you want couple good legit plays look at ACRV, BITF and IMRX all are well positioned for coming weeks. Bought some RCKT today, PDUFA 28/3 don’t hold for long
Thx for the information, I don't really track daily volume. I'm still kind of newbie in investing lol I'm pretty much loaded up in IMRX as much as I can afford at the moment. I plan to add more in the beginning of April when I have some dry powder if the stock hasn't started to rally up too much above my average.
It depends what you consider short term. RCKT has the fda decision march 28. So that would definitely be considered short term in my opinion. IMRX has lots of catalysts this year, so it’s probably a 3-12 month play at minimum . MRAM is a longer hold for me. I’m just buying it and throwing it to the side right now . As data centers and technology gets more and more demand, MRAM will continue to benefit. Avalanche put out a frivolous lawsuit against MRAM. So as soon as that is resolved, the stock price will likely bounce 20% immediately. But either way, MRAM seems to be a good longer term bet, if you don’t need the money asap .
There was a massive volume spike in IMRX the last 30 minutes of trading on Friday. Like 7 million shares traded in 30 minutes. Not sure if that means someone knows something ? But it spiked the price up, and did 6-7x the average daily volume in a few minutes.
RCKT - fda decision by march 28. 80% approval odds IMRX - massive volume spike 10 minutes before market close on Friday. Multiple upcoming catalysts over the next 1-2 months . Could be a big move coming after the massive volume spike
RCKT - fda decision by march 28 IMRX - speaking at conference April 17th. Plus some other readouts coming in the next couple months before phase 3 trials start in June
So, do you believe RCKT, IMRX, and MRAM are short-term plays?
I added more IMRX yesterday and now have 323 shares with avg 4.35$. I also bought FEMY stock a small amount (300 shares) at 0.6 even though I'm overextended in med stocks but extra 180$ is not much for such amount of shares and potential though. It is dangerous pick because it has reverse split looming in July but the upcoming ER could push it past 1$ and if you ignore the possible reverse split (which is obviously hard to ignore lol), it has already revenue generating products and more coming in the pipeline. Also I previously had 200 shares of High Tide and added extra 100 shares after great quarter earnings even though the share price dropped in market openings like a rock even after move up, but not so much as Palladyne after their latest contract announcement which is really "WTF is going on" which moved to 7.5 pre-market oppen and dropped to 6.3 like in a hour after market openings and started in 6.9 instantly when market opened. High Tide is a Canadian cannabis stock which is not the most attractive sector but this company is the exception because it has great fundamentals/financials and outlook (it is expanding aswell), undervalued (IMO) and could be a significant player when cannabis is more widely legalized in USA (it is pretty much leading the pack in retail cannabis in Canada). It kind of has the same vibe as LifeMD which has bigger competitor Hims&Hers which everybody focuses on, High Tide is less talked about and usually Tilray is the company that is focused on but High Tide has better financials even though the revenue is smaller, potentially great outlook in the future, low debt and good leadership aswell. I think this company may be worthy to DD for you, it is less speculative and with good fundamentals even though the cannabis sector is highly competitive but they focus on retail aspect of cannabis sector and have strong footing in there.
I just read that IMRX is going to be presenting at a conference April 17-23 about combining their med with some other meds. IMRX has zero chance of dilution, and a proven med. That’s almost impossible to find in a small cap biotech space . Plus, they are trading near enterprise value, so there’s major upside potential
Sounds like you got it figured out pretty good! The market is going to be tough for a bit with the Iran crap, and with trump getting silly . Best thing to do is just slowly average in to stuff . I bought more RCKT and IMRX today . Been buying MRAM also
That's what I thought aswell that the best treatment before recent IMRX results in January was with like 30% survival and with IMRX drug was 65%. I had a small position in it before last results in January (avg price was 7.06) and it fell hard but I figured I just avg down because people had either higher expectations of survival rate (like 75%+) or it was just sell the news trade for a lot of people. Next catalyst is probably in May or June and it is just hold and forget in the meantime.
I have a fear with RCKT bc my friend invested in this stock last year when patient died in trials and the stock fell pretty hard after that. My friend stills hold the stock though waiting for the pump up in price. I feel that I have overextended my portfolio with biotech related stuff (DRTS, IMRX, MBOT, MDAI). Yesterday I added 100 shares to DRTS, DDD, NB, CTM, PDYN, MBOT and Kopin (Ondas and UMAC bought Kopin shares with 2.10 price last September for long-term potential, my average is 2.22 and sitting with 300+ shares, earnings coming up in a week or two) I also bought 200 shares of Canadian Uranium mining company Denison Mines which is under 4$ right now, should be a good entry price but there seems to be a dilution fear with it right now)
Heck ya! That’s some great gains ! I got in AMPX at $9.70 and sold at like $18 I think . I just keep adding to IMRX and throwing it to the side. Hopefully it will be a good profit later in the year. I try to have different stocks with different plans for profit . Some are stocks that I’m looking for profit in a few days or week, and some are 6 months or years . IMRX is one that I’m hoping for this year, but likely much sooner . I’ve been adding RCKT too. They have a decision on march 28th
The good thing about the biotech stuff is , it takes a number of years for a competitor to bring a drug to market . With IMRX , they have a cash runway until 2029, no debt, and they have already shown that their med is at least 2x better than nothing . Pancreatic cancer is a killer . Anyone with family members that had it would agree that they would love to have a med that gives a 2x better treatment , compared to nothing . The stock is trading near cash value . I know I can’t be right on every stock pick. But I’m pretty confident this one will make people a chunk of money sometime this year. I just keep adding , and setting it to the side
Another small drop of IMRX today, I just posted a possible explanations with ChatGPT screenshots in Stocktwits that could possible explain things. I've got a lot of fate for this company also and I can handle price drops mentally well bc there's a lot of red in my portfolio anyway lol (overall portfolio is up 26% though and gradually increasing for the last month). I also sold all my AMPX shares today and made 78% profit (2100$) because two insiders sold a significant amount of shares recently and it seems that the price has been hovering around 19 quite a bit of time and AMPX has tendency to drop agressively after run-up. I may buy back in later if it drops enough. I'm trying to build a little safety net for my portfolio and keep it more stable hopefully lol Thought I mention that aswell since you previously mentioned you have a position in AMPX, not trying to encourage to sell you though if you already haven't lol
IMRX - one of the best upside potentials at current prices . There’s not many other small cap stocks that I have as much faith in for 2x - 3x + gains by the end of 2026. I added a picture of my 1 year gains , that way you might be more intrigued to look in to immuneering - IMRX (I’ve never done options trading before either ) https://preview.redd.it/94cewj5kfjpg1.jpeg?width=1179&format=pjpg&auto=webp&s=9b74468eade7c3ea3188a5fc6d02fd830f3ab360
Exactly . That’s why averaging in to a stock is so important usually . I’m extremely confident in IMRX over the next 3-12+ months though. Unless there’s some unforeseen change , it should be fine. I also have family that works there lol
I suppose that there is a tiny chance that RZLV could "fake it till it makes it". I cringed when I looked at some comments in Dan Wagner X timeline (if these are not bot comments ofc) that someone put their life savings and 70% of portfilio in Rezolve and told Dan not to let him down and he responded along the lines that "I'll do my best" lol I hope that the people investing in this company either sells it short-term or realize that they have made a mistake. I just sold my RZLV on run up at 2.83, don't care that I lost a bit money because LAES shares just fell after dilution announcement and bought 108 of them pretty much at the bottom (hopefully) and moved rest of the money to IMRX and got my average to 5.48 now, which is nice bc 2× that price would be precisely at 11$ lower end analysts price target .
IMRX had a random drop on Friday, so I added more again lol. But it’s always good to take some profit whenever you feel like it’s a good time ! Glad you made some money!
IMRX is one of the best upside potential trades at these prices . Over the next 3-12 months , immuneering has a number of catalysts coming . They have a cash runway through 2028. No debt. Great results for pancreatic cancer treatment through phase 2 trials . Phase 3 starting in June . I’ve been adding a lot lately . I’ll continue adding heavily under $6 - $6.50 range . This is one of my highest confidence trades of 2026. I’ve been doing pretty good so far https://preview.redd.it/9kqzy5uw35pg1.jpeg?width=1179&format=pjpg&auto=webp&s=04faa08cda7920bc4eaf0505da58f28965fa578c
I actually changed my mind yesterday and sold all my LifeMD stock for the time being for 40% profit and decided to move that money to MBOT (bought 213 shares, it has 2 catalysts coming up in 1 month time and don't want to pay premium for the stock later, it has already FDA approval and it probably has a dilution also coming up during a year but it seemed like a good idea for me to get it at 2.79 price before it rallies further) and the rest to IMRX (currently have 246 shares of it at 5.56). I added LifeMD stock to my watchlist for the time being and buy in again. Now we both have to root for the price drop and shorters to short it in the meantime lol
It’s always good to do your own research and make your own decisions. I have extreme faith in IMRX over the longer term. I buy on red days. I really like buying around $5. It might take a few months or more to get the price up. But I feel like it’s one of the safest biotech plays with some of the best upside potential on the market. As long as you don’t need the money immediately, and you can make consistent buys when the price is down, I think it will be a very easy trade ! They have already proven their med has massive potential!
I decided to play it more safe and keep my current position in LifeMD even if current gains fade away in next few months bc biotech like RCKT is riskier even though I have huge conviction in DRTS and IMRX - those are the 2 that I feel confident in "rolling the dice" (long cash runway, insiders buying and good recent results despite share price drop in IMRX and proven tech + long cash runway in DRTS) and I can sleep well at night with those pics lol The thing is I really don't have that good financials to take more risks in investing so I try to find balance between taking risks that I can afford and try to make good enough gains (whatever that may be) at the same time.
I’d recommend that you do the most research you can, then make your own educated decision. The things I saw are just my opinions , and I’m definitely not always right lol. The best thing to do would be maybe set a stop order , that was if it gets down to a certain amount, you should be fine. Also , with RCKT , I’m just playing it as a short term trade . It’s not something I’m going to hold long . If you are planning to hold for a year or more , LFMD and IMRX are probably great at current prices. IMRX was in the low $5’s until recently. But it’s going to be easy money over the next 6-12 months
The Yahoo finance had a wrong date of Ondas earnings a couple of days ago, I just realized that yesterday. I guess we have a similar average in AMPX as well, I'm up 75% after market closing. It is starting to get tempting (up 47%) for me to take profits of LFMD. Since there is a great chance of FDA approval for RCKT, I'll move half of LFMD money to RCKT and half to IMRX and hopefully grow it there in the meantime.
Similarly to the other replier Prior-Message5571, i have been following your track record and recommendations. I am still currently invested in (DGXX, LFMD, IMRX, BLNE and most recently RCKT). But i also have my portfolio spread between 17 stocks. Maybe I should trim it down to maybe about 10 like your statement. Out of the stocks I mentioned I know ONDS is your long term that you have been piling up, what are your opinions on keeping them? And any additional that I may have not mentioned, looking long term to grow? Thank you so much!
Thanks ! I bought a pile of RCKT the last few weeks. I’ve also got a large pile of IMRX . I think it has some huge potential through 2026 !
What's your average in IMRX and do you plan to hold through trials? (My plan is if the share price is at least 100% of my current average before trials, then I sell. My average is 5.56 currently)
IMRX - free money to buy and hold for 6 months at current prices . MRAM is a great price . If you missed MU and Sandisk, then get in MRAM LFMD has earnings this week. If guidance is good, this should rally off its near 52 week lows . DGXX has tenant news coming in the next 30 days. It’s a good time to accumulate. RCKT - volume is increasing fast ! FDA decision coming by march 28 with 80% approval chances. Get it before everyone else!
Thanks for your insight, thanks to you I‘m invested in MRAM, IMRX and DGXX, all are doing well rn. Only about LFMD I’m not so sure about, lost money there. Are there any catalysts coming?
MRAM - earnings on Wednesday. RCKT - fda decision by march 28 IMRX - great time to accumulate shares . Will be easy money if you hold through summer . DGXX - they had news today . Supposed to start running their new ARMS setup the 3rd week of march . LFMD - earnings next week. Stock is near a 2 year low, but the company is in better shape than ever . Could be an excellent time to buy .
MRAM has earnings this week. RCKT should be a great one , since they have the fda decision by march 28 IMRX is an easy winner if you have patience to buy and hold until mid summer ONDS should be up with the war stuff, since they bought multiple Israeli defense companies. They also have earnings next week
MRAM has earnings next week . LFMD has earnings in 2 weeks . RCKT has fda news coming march 28 IMRX has trials starting in a few months, and data readout later in march . ONDS earnings is mid march. Should be a fun month !
IMRX , MRAM , ONDS , LFMD , DGXX , LUNR . Some of those aren’t penny stocks at the moment , but they all were in the last 6 months , and they all have a lot of potential
Same here. I’ve got a pile of shares . Planning to hold at least until late this year. In my opinion, IMRX is one of the best trades on the market right now for a 6-12 + month trade
IMRX is starting to head back up. It will be one of the easiest trades of the year . Buy and accumulate between now and June
IMRX , LFMD , MRAM , DGXX . All have major catalysts coming over the next 1-6 months . All have no debt , and they have excellent potential
IMRX is going to be one of the easiest 3x between now and summer time
I’ve been adding very consistently with IMRX . It’s amazing how under the radar this company is. When phase 3 trials get closer to starting , I’d bet there will be a major run up. I just keep adding for now, and will be rewarded later this year
Awesome ! As long as RZLV audited financials are exactly what they have been claiming , it should be easy gains . But, if it’s not , then it will dump! It will be interesting to see what happens in April! IMRX will be free money when it gets closer to starting phase 3 also
IMRX , DGXX , LFMD , MRAM , RZLV . These all have potential to 3x + this year
IMRX , LFMD , DGXX , RZLV - these all have potential to 3x + this year without too much problems
IMRX is one of the best plays to make money over the next 6 months . RZLV has some major potential if the audited financials are what they claim . DGXX has contract news coming soon. This will be easy money as long as bitcoin doesn’t drop too much before then LFMD is near 52 week low, even though they paid off all debt and are in the best financial position they have ever been in. This is a great one to DCA until march when earnings come out .
SLS, IMRX, MAIA and CHRS are up 60-200% for me. I recently had GPCR and NRXS double/sold too. I got lucky with them I'll admit but biotech is still a favourite. I wouldn't recommend yolo'ing 10k into one stock though.
I’ve been making some nice money on **$BLNE** thanks to you — much appreciated. At this point, I’m thinking I might as well just follow you into battle. So here’s the plan: * **$LFMD** instead of **$HIMS**, * **$DGXX** instead of **$IREN**, * **$IMRX** instead of **$IBRX**. No hedging, no overthinking — just vibes and conviction. It’s officially all or nothing. Hopefully by year-end, I’ll be sipping a mojito in the Maldives. Wishing you the best of luck — and let’s see how it plays out.
DGXX , LFMD , IMRX , RZLV . These are getting my money at current prices
IMRX - immuneering— no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
IMRX - immuneering— no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
I’ve been adding a lot the last few weeks. Planning to hold until at least halfway through phase 3 trials on this one. IMRX has been one of the best stocks to make money the past couple weeks. The massive market over reaction was great !
I bought the dip at 4.8, market expecting >70% but it came at 64% hence the sell off. IMRX has better positioning versus SLS.
IMRX — no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
IMRX — no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
No, I mean IMRX - immuneering
Do you mean IBRX instead of IMRX?
IMRX — no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
IMRX - been buying like crazy after a massive over reaction a few weeks . The insiders have been loading up the past couple weeks. The company has no debt . They are funded through 2029, so there’s no dilution worry. Their news wasn’t bad in any way a few weeks ago. The overall survival rate was 64%, when the standard of care is like 34%. The readout was also after 13 1/2 months instead of 12 months . Phase 3 trials start in June. There’s some tumor shrinkage news coming out before then. I bought a bunch when it was $1.50, and rode it to $9. There was a big after hours short squeeze back in September when they did a readout after hours. It went from like $9 to $17 before announcing a share offering . The upside potential on this is excellent. I plan to continue loading up until the mid $6 range, then I’ll let it ride through phase 3 trials . I’m not saying it will jump up in 1 day, but as the phase 3 trials starts, this will essentially be an incredibly safe bet.
I usually stay away from biotech stocks, but I’ve got a relative that works at IMRX , and I’ve been able to hit it perfectly the last 12-16 months . I have some big faith in this one over the next 4-8 months .
IMRX — no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again . I’ve got a relative that works there , so I know the potential is great for them.
IMRX - No debt, insider buys almost every day lately , massive over reaction from the market a few weeks ago, funded through 2029 so no dilution , phase 3 trials start in June . One of the best upside potential stocks I’ve found lately . Been buying like crazy the last 2 weeks, and planning to hold until the 2nd readout on phase 3 trials and see how it looks .
It actually ran up faster than I expected. I figured it would be between $3-$5 when the housing market got better . So it was a pleasant surprise that it’s already up this much. It will really depend on the next earnings call. I’ve been buying IMRX like crazy the past 2 weeks
I’ve been buying IMRX from the low $4 range. I’ve bought like a madman lately . (Not saying anyone else should buy it, just stating what I’ve been buying) there’s no telling if it goes up or down in the near term, but I’m very confident in it between now and mid - late summer time
Awesome ! Glad to hear it . I’ve been buying IMRX since it hit like $4.15. Insiders have been buying almost daily . Expecting to get around $$7-$9 by June when phase 3 starts . No debt, insider buying , great results on their med. Massive market over reaction a few weeks ago . The news wasn’t even bad in the slightest way.. I’m not saying to buy it or not. But I’ve been buying like crazy, and I’ll probably keep adding until $6-$7. No chance for dilution either . They are funded through 2029
Some of the ones I followed today IMRX up 10% GORO up 17% Rime up 33% Segg -10% Honestly, do yourself a favor and stay away from meme stocks like Segg (which is basically everyone hoping it will rocket short term gains and unsustainable) and IBRX (unless you bought low already). The Stock Market is pretty random with who it chooses to bless at our level, so don't use money you can't afford to lose and believe in the stockmarket
lol exactly! I’m not big in the bio tech stocks, but I have family that works at IMRX , so I got in around $1.50. I mentioned it before their LLY partnership on here when it was like $1.50. Unfortunately with the data that came out yesterday, only 3 people in the company can see the results , that way there’s no insider trading. So my relative wasn’t able to see the data ahead of time unfortunately. It will climb back up again. They have no debt and a fat pile of $240m cash
I sold the shares I bought the last couple weeks near market close . Made like 20% on my money. I hold shares at a cost of like $2.50 average also. Their readout data was really good , but it wasn’t as good as expected. But usually these stocks are good to buy a few weeks ahead of a catalyst, then cash out the day of the news . Although, IMRX actually has some serious potential long term. I hold a good chunk of shares still
Thanks ! IMRX is way up today. I’ve been telling people all week lol. Some of my picks take a few months or more to pop though .
I bought more LFMD today. My company hired ONDS so i learned about them because they used drones to inspect our equipment. I was interested in space stuff and I spend about 2 hours per day researching, so I found those. ASTS had their office next door to our business in west Texas , so I met a few of the technicians there, and they took me in a walkthrough when the stock price was like $3. I never expected it to run this high, but I bought a good chunk of shares the day they let me come walk in their shop. RKLB I bought because I thought it would be huge as the future went on. I didn’t expect it to grow this fast though. IMRX I have family that works there so I knew about the LLY partnership. I mentioned it on Reddit when it was $1.50. Then it ran to $9. I’ve been mentioning IMRX on Reddit the past week, and it’s up huge today for their OS readout . I like to get in and accumulate shares of good companies a few months before they take off. Sometimes it’s faster than I expected, and sometimes it’s slower . My real estate play (BLNE) might take a bit longer to take off, due to economic reasons. But I’m confident in it for later this summer
IMRX rising nicely into tonight's news
Opinions on IMRX, institutional ownership went up over 6x since a few months ago, trial data coming today?
IMRX has their 12 month OS readout after hours on Wednesday. The company has no debt. $230m in cash , so no dilution. Lots of insider buying . Volume has been increasing the last few trading days . Good luck !
Big update for DGXX https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/digi-power-x-announces-1-150-year-over-year-liquidity-growth-and-prov-1124350 IMRX has their 12 month OS readout tomorrow after hours .
IMRX has their 12 month OS readout tomorrow after hours . Their 9 month readout caused a short squeeze. They have no debt and a mountain of cash
IMRX has their 12 month OS readout on January 7. There’s some big potential there. LFMD for a good value , get it at the bottom before it runs again after they announced a partnership with NVO today . DGXX one of the best value bitcoin mining companies that turned HPC / data center . They are expecting an announcement for a contract any day now . BLNE to get In a real estate play before the market rotates into that sector . This will be an easy 2x + in the next few months
IMRX has 12 month OS readout on January 7 for pancreatic cancer treatment in phase 2 trials
ONDS , DGXX , LFMD , BLNE , (IMRX does their 12 month OS readout on the 7th this month, so there might be some good potential there too)
After doing a bit more research, my guess is they will release the phase 3 fda update , then (assuming it’s good) the stock price will run up a bit and they will do a share offering . That is the logical play. IMRX has 12 month OS readout on January 7 this week. On their 9 month update, the share price ran huge after hours , but they announced a share offering almost immediately. But now they have 3-4 years of cash.
IMRX has 12 month OS readout after hours on January 7 in case anyone wants to get in on the action
LFMD , DGXX , BLNE - these are a few more that haven’t popped yet. Lots of people post junk on Reddit. Looks like you got in early on some of the same stocks as I did . (ASTS , RKLB , ONDS , IMRX , HOOD) . It’s always good to see a few other people on here that don’t just post the same stuff that everyone else already posted, or some pump and dump company
IMRX and GANX have attractive entry points rn
SLS still is a gamble, there is a real case that current valuation is fair/high and people banking on something happening during JP Morgan event will probably be disappointed which could cause a (big) drop VKTX, IMRX and GANX have way more room for steep rises in the coming weeks imo
IMRX has 12 month OS data readout on January 7. Some huge potential possible !
I would live IMRX fails, and I gonna load on the dip :)
Have about 400 IMRX shares
BLNE for the housing market rebound DGXX for an undervalued bitcoin mining company that converted to data center stuff IMRX has 12 month readout coming January 7th
IMRX has their 12 month update coming January 7.
IMRX announcing news / updates / regulatory feedback on January 7. Volume has been increasing the last few days. This has some major potential. Last update in September caused a massive squeeze and the price ran to $17 after hours , before announcing a share offering . Now they have a mountain of cash and no debt . So this announcement could really move the price . Insiders have been buying the past few months also
If anyone wants to make some easy money… IMRX - big news coming https://www.investing.com/news/company-news/immuneering-to-provide-12month-survival-data-for-pancreatic-cancer-drug-93CH-4421095
IMRX - this will be huge https://www.investing.com/news/company-news/immuneering-to-provide-12month-survival-data-for-pancreatic-cancer-drug-93CH-4421095
Also check out IMRX - https://www.investing.com/news/company-news/immuneering-to-provide-12month-survival-data-for-pancreatic-cancer-drug-93CH-4421095
IMRX - better hurry https://www.investing.com/news/company-news/immuneering-to-provide-12month-survival-data-for-pancreatic-cancer-drug-93CH-4421095
Yes, IMRX is starting phase 3 trials in the coming months. Their pancreatic cancer treatment has been insanely good so far. They are expecting regulatory feedback in the next few weeks also
DGXX looking good for a possible continuation, are you expecting news on IMRX?
BLNE / DGXX / IMRX / maybe some BZFD
If you do enough research and find / hold good stocks , this isn’t true. I got ONDS at 70cents / got ASTS at $3.80 / RKLB at $4 / HIT at 80 cents before running to $3.50 / IMRX at $1.40 / BBAI at $2 . Along with some others I do hours of research each day. BLNE is my next pick to make a pile of money over the next few months